Dallas- OTCPicks.com’s Daily OTC Stocks Newsletter presents a range of the hottest small cap, micro cap and penny stocks trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and micro cap traders to meet up and discuss their top stock picks.
Visit http://www.otcpicks.com/hotpicks.htm today to sign up for our Free Daily Email Newsletter and News Alerts.
Sign up for our Free Red Hot Stock Picks List at
http://www.otcpicks.com/hotpicks.htm
Join us on Twitter at
www.twitter.com/otcpicks
Join us on Facebook at
www.facebook.com/otcpicks
INNOVATIVE HEALTH SCIENCES INCORPORATED (OTC: IHSN) "Up 80.77% on Tuesday" Detailed Quote:
http://www.otcpicks.com/quotes/IHSN.php
Innovative Health Sciences, Inc. is focused on acquiring companies that are leaders in their respective market niches and have the potential for additional upside. Acquired in 2010, Harrington Multi Media Marketing (HM3) is a leading producer of infomercials and short-form direct television spots and developer of Internet-based marketing campaigns and transactional websites. HM3 also offers complete turnkey solutions to launch new consumer products including: assistance with outsourcing products and prototype development; set-up and management of call centers; product fulfillment and customer service; credit card processing; purchasing and management of media outlets, including telephone sales, direct response television (DRTV), and Internet sales. IHSN News: May 4 - Innovative Health Sciences, Inc. Receives Offer to Purchase 100% of Outstanding Shares Innovative Health Sciences, Inc. (OTC: IHSN) announced that there was a special meeting of the Board of Directors to discuss a Letter of Intent received by the Company to buy 100% of the Company's outstanding shares. The Letter of Intent, received April 29, 2010, is presently being reviewed as to the current terms and conditions of the offer. While the Board has come to no conclusions, the final consensus was very favorable. The current offer is higher than the 52 week high of $0.35 per share. In deciding to proceed with the sale, the Board has contacted its corporate counsel as to whether the Board has the authority to accept the offer, without holding a shareholder meeting. Innovative Health Sciences, Inc in Talks With Suitor for Sale of Company Innovative Health Sciences, Inc. (OTC: IHSN) announced that there was a special meeting of the Board of Directors to discuss a Letter of Intent received by the Company to buy a majority stake of the Company's outstanding shares. The Letter of Intent, received April 29, 2010, is presently being reviewed as to the current terms and conditions of the offer. The deal characterizes an attractive package with an offer suggested to be substantially above the current trading range. While the Board has come to no conclusions, the final consensus was very favorable. In deciding on proceeding with the sale, the Board has concluded to consult with its legal counsel as to whether the Board has the authority to accept the offer, or whether a shareholder meeting must be called to vote on the matter. NEWRON SPORT (OTC: NSPT) "Up 66.67% on Thursday" Detailed Quote:
http://www.otcpicks.com/quotes/NSPT.php
Newron's patented tandem device is a unique product that focuses on both recreational use and enhancing sports performance by allowing the enjoyment of inline skating on hard and rough surfaces without the vibrations and loss of balance because of surface imperfections as the Newron skate system absorbs these imperfections and provides the inline skate user the feel of a smooth glide, stride and maneuverability of an ice skate, all while offering the user a safer and more efficient braking system than the conventional inline skates. The Newron inline skates is intended both to help prevent injury and to improve athletic performance via its confidence enhancing attributes among inline skate sports participants. The Newron inline skate seeks to foster the enjoyment of sports by people of all ages. NSPT News: May 4 - Newron Sport Receives Order and Finalizes Deal With Source for Sports Newron Sport (OTC: NSPT) announced that it has finalized an agreement, which has resulted with its first order, with one of the most recognized sports distributors in North America, Source for Sports (www.sourceforsports.com). This order starts the distribution of Newron skates to over 200 affiliated retailers. Source for Sports has agreed to proceed with its first order of the Newron inline skates as a new and innovative product that will complement and enhance the image for Source for Sports. Mr. Robert Ritondo, President of Newron Sport N.A. stated, "The response from the affiliated members is tremendous and they are anxious to get their hands on our products and begin introducing them to their customers. On only the first day of this agreement we already received two purchase orders from affiliated members." "We knew that our products would be well received, but this news of two affiliates jumping on board immediately, to start the ordering process is absolutely fantastic. If each affiliate was to order 1 pair of each size through all 200 affiliates, it would have a huge positive effect on the bottom-line." PLATEAU MINERAL DEVELOPMENT INCORPORATED (OTC: PMDP) "Up 60.00% on Tuesday" Detailed Quote:
http://www.otcpicks.com/quotes/PMDP.php
Plateau Mineral Development, Inc. specializes in the exploration and development of energy sources. Its partner, Plateau Mineral Development LLC, has been in existence for over five years with successful new wells and rework wells selling both gas and oil. PMDP News: May 3 - Plateau Mineral Development, Inc.'s Technologies Can be Modified to Assist in Cleaning Oil Spills Such as the Current Spill in the Gulf of Mexico Plateau Mineral Development, Inc. (OTC: PMDP) announced that its partner company, Environmental Solutions (EnSol), has a technology that can be modified to assist in cleaning up oil spills such as the current one in the Gulf of Mexico. While the EnSol technology would require some modifications to meet the exact needs, those changes would be minor. EnSol's technology can be used to reclaim the oil and tar, whilst restoring the beaches. It would take in a volume of contaminated sand, dissociate the components, extracting the oil and tar, thereby allowing clean sand to be deposited back onto the beach. Robert Matthews of Plateau Mineral Development, Inc., states, "The oil spill in the Gulf of Mexico and its negative environmental impact is of significant importance at present. It is our goal to eventually use the green, environmentally-friendly EnSol technologies in an effort to help with the clean-up process of this any future oil spills." WELLSTAR INTERNATIONAL INCORPORATED (OTCBB: WLSI) "Up 85.71% on Tuesday" Detailed Quote:
http://www.otcpicks.com/quotes/WLSI.php
Wellstar International, Inc., through its wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website. WLSI News: May 4 - Wellstar International, Inc. Announces Initial Implementation of Beta Test Wellstar International Inc. (OTCBB: WLSI) has announced they have started their second Beta Test in a Long Term Care Facility. Wellstar has implemented its second TMI Imaging system; this system will help in not only diagnosing but predicting deep tissue injuries which then can develop into bed sores. By detecting early tissue damage, the success of avoiding bed sores is greatly increased. TMI views this as one of the last steps to be able to implement its system in the LTAC market. With more than 700 LTAC’s across the United States, TMI anticipates in excess of revenues that could exceed more than 1 million dollars per month from this segment of the marketplace. Long term acute care facilities or LTAC’s, are facilities that generally house immobile patients and those patients are considered high-risk in developing a pressure ulcer. TMI plans to use its technology with the nurses on call to monitor and help diagnose any change in the patient’s tissue around the specified areas. The Beta Test is scheduled to run for 90 days. During this period, images will be captured of existing patients on a time schedule, as well as any new patient admitted to the facility will also be imaged. The data that will be compiled will be used to determine the type of specific care for the patient, as well as to demonstrate the practical use of the TMI System within the workplace. MISONIX INCORPORATED (NASDAQ: MSON) "Up 30.57% on Tuesday" Detailed Quote:
http://www.otcpicks.com/quotes/MSON.php
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices and laboratory equipment worldwide. The company operates in two segments, Laboratory and Scientific Products, and Medical Devices. The Laboratory and Scientific Products segment offers Sonicator ultrasonic liquid processors; Aura ductless fume enclosures for filtration of gaseous contaminates; Labcaire autoscope and Guardian endoscope disinfectant systems, which controls and eliminates hazardous vapors, noxious odors, and particulates in the laboratory; and Jet AER autoscope, a reprocessing, disinfecting, and rinsing equipment. The Medical Devices segment provides Auto Sonix ultrasonic cutting and coagulatory system, ultrasound systems, replacement transducers, ultrasonic lithotriptor, ultrasonic neuroaspirator used for neurosurgery, and soft tissue aspirator used primarily for the cosmetic surgery market. It also offers ISIS systems for the protection of personnel, products, and the environment from airborne hazards; and Sonablate 500 for the ablation of cancerous tissue in the prostate. The company primarily serves medical, pharmaceutical, semiconductor, biotechnology, and forensic industries. Its customers include end users, such as doctors, hospitals, and distributors. The company markets its products through direct salespersons, distributors, manufacturing representatives, and catalog listings. Misonix was founded in 1959 and is based in Farmingdale, New York. MSON News: May 3 - US HIFU Receives Unanimous Approval to Continue the Clinical Investigation of High Intensity Focused Ultrasound (HIFU) for Treatment of Prostate Cancer US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, received unanimous approval from its Data and Safety Monitoring Board (DSMB) to continue enrollment in its FDA-approved prospective clinical trial investigating the use of high intensity focused ultrasound (HIFU) technology delivered via the Sonablate® 500 ("Sonablate HIFU") medical device to treat localized primary prostate cancer. US HIFU intends to submit the completed data to the FDA in support of its request for commercial approval to treat primary prostate cancer in the U.S. Sonablate HIFU destroys diseased prostatic tissue with extreme heat generated from focused ultrasound waves. The ultrasound energy is delivered in rapid-fire succession to targeted tissue throughout the gland. The tissue at each target is destroyed while surrounding tissue remains unharmed. The DSMB, an independent group of experts that monitors clinical data to ensure patient safety during any clinical trial process, made no changes to the existing criteria following its review from the initial cohort of enrolled patients. "This is quite an exciting milestone in this process. Unanimous approval from the board reaffirms that we are right on track with our study," said US HIFU CEO Steve Puckett, Jr. "I am confident that we will complete the trial and certainly remain hopeful that this minimally invasive prostate cancer treatment will be available in the U.S. in the near future." Additionally, US HIFU continues active enrollment in the FDA-approved prospective clinical trial investigating Sonablate HIFU for the treatment of recurrent prostate cancer. As with the primary prostate cancer clinical trial, US HIFU intends to submit this completed trial data to the FDA in support of its request for commercial approval to treat recurrent prostate cancer in the U.S. "We are proud to have 18 well-known and respected institutions on board as our current trial sites," said Dawn Rice, director of clinical affairs. "We are working diligently to round out the list of sites as well as to enroll additional participants in both the recurrent and primary trial." ABOUT USHIFU US HIFU (USHIFU, LLC), a privately held healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. US HIFU manufactures the Sonablate® 500 medical device and is focused currently on treating primary and recurrent prostate cancer using Sonablate® HIFU. The company is engaged in ongoing research for technological advancements for the Sonablate® system or other ultrasound applications. ABOUT THE SONABLATE® 500 The Sonablate® 500 is a minimally invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by Focus Surgery, Inc. and is manufactured in part by Misonix, Inc. (Nasdaq: MSON), which also holds distribution rights in Europe. Takai Hospital Supply Ltd. distributes the Sonablate® 500 in Southeast Asia. The Sonablate® 500 is not approved for use in the U.S. The Sonablate® 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate® 500 for the treatment of prostate cancer. About OTCPicks.com OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap and penny stocks. The web site features growing micro cap and penny stock companies. We publish a daily Free email newsletter highlighting the most active Pinksheets, OTCBB and penny stocks. To feature a company on our web site please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com. Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. Disclosure: OTCPicks.com has been compensated five thousand dollars by a third party for IHSN advertising and promotional services. OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
